191 related articles for article (PubMed ID: 29642222)
1. Management of pulmonary embolism after recent intracranial hemorrhage: A case report.
Lee WC; Fang HY
Medicine (Baltimore); 2018 Apr; 97(15):e0479. PubMed ID: 29642222
[TBL] [Abstract][Full Text] [Related]
2. [Pulmonary Embolism Despite Rivaroxaban in an Obese Patient].
Schuh T; Stöllberger C
Dtsch Med Wochenschr; 2017 Oct; 142(20):1548-1551. PubMed ID: 29017215
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary embolism after brain hemorrhage in a hypertensive patient: the therapeutic dilemma.
Oneglia C; Gualeni A
J Thromb Thrombolysis; 2008 Apr; 25(2):231-4. PubMed ID: 17534695
[TBL] [Abstract][Full Text] [Related]
4. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
[TBL] [Abstract][Full Text] [Related]
5. Effective diagnosis and treatment of pulmonary embolism: Improving patient outcomes.
Meyer G
Arch Cardiovasc Dis; 2014; 107(6-7):406-14. PubMed ID: 25023859
[TBL] [Abstract][Full Text] [Related]
6. [Intracranial hemorrhage due to pulmonary thromboembolism in heparin therapy and therapeutic management of patients hospitalized with massive pulmonary embolism after discharge].
Beşli F; Keçebaş M; Alişir MF; Güngören F
Turk Kardiyol Dern Ars; 2013 Apr; 41(3):228-32. PubMed ID: 23703559
[TBL] [Abstract][Full Text] [Related]
7. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
[TBL] [Abstract][Full Text] [Related]
8. [Acute circulatory failure caused by primary pulmonary hypertension or pulmonary embolism].
Meyer G; Sanchez O
Rev Mal Respir; 2000 Feb; 17(1):51-65. PubMed ID: 10756556
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of pulmonary embolism with recent intracranial hemorrhage.
Endo H; Kubota H; Sato M; Sudo K
Ann Thorac Cardiovasc Surg; 2005 Aug; 11(4):256-9. PubMed ID: 16148874
[TBL] [Abstract][Full Text] [Related]
10. Multidisciplinary approach to the management of patients with pulmonary embolism and deep vein thrombosis: a consensus on diagnosis, traditional therapy and therapy with rivaroxaban.
Imberti D; Becattini C; Bernardi E; Camporese G; Cuccia C; Dentali F; Paretti D
Intern Emerg Med; 2018 Oct; 13(7):1037-1049. PubMed ID: 29520700
[TBL] [Abstract][Full Text] [Related]
11. A Case of Isolated Unilateral Right Renal Vein Thrombosis Associated with Bilateral Pulmonary Embolism Treated with Rivaroxaban a Direct-Acting Oral Anticoagulant.
Matta A; Elenizi K; AlHarthi R; Moussallem N; Elhajjaji N; Lhermusier T; Carrié D
Am J Case Rep; 2019 Aug; 20():1152-1154. PubMed ID: 31383838
[TBL] [Abstract][Full Text] [Related]
12. Looking beyond the D-dimer.
Kelleher MS; Selinger HA
J Fam Pract; 2011 Jul; 60(7):400-3. PubMed ID: 21731917
[TBL] [Abstract][Full Text] [Related]
13. Outcome following intracranial hemorrhage associated with novel oral anticoagulants.
Kasliwal MK; Panos NG; Munoz LF; Moftakhar R; Lopes DK; Byrne RW
J Clin Neurosci; 2015 Jan; 22(1):212-5. PubMed ID: 25065949
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary embolism: update on management and controversies.
Duffett L; Castellucci LA; Forgie MA
BMJ; 2020 Aug; 370():m2177. PubMed ID: 32759284
[TBL] [Abstract][Full Text] [Related]
15. Recurrent venous thromboembolism after discontinuation of rivaroxaban therapy in a patient with antiphospholipid syndrome.
Yagi S; Nishiyama S; Abe T; Sata M
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30635311
[TBL] [Abstract][Full Text] [Related]
16. Comparison of rivaroxaban mono-therapy and standard-therapy adjusted by CYP2C9 and VKORC1 genotypes in symptomatic pulmonary embolism.
Duan L; Zhang N; Yan H; Guo Y; Hong C; Yang X; Su X; Chen R; Zhou Y; Zhong N; Liu C
Clin Chim Acta; 2016 Aug; 459():25-29. PubMed ID: 27155586
[TBL] [Abstract][Full Text] [Related]
17. Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations.
Prandoni P
Thromb Res; 2014 Aug; 134(2):227-33. PubMed ID: 24875390
[TBL] [Abstract][Full Text] [Related]
18. [The optimal duration of anticoagulant treatment following pulmonary embolism].
Couturaud F
Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
[TBL] [Abstract][Full Text] [Related]
19. Safe-dose thrombolysis plus rivaroxaban for moderate and severe pulmonary embolism: drip, drug, and discharge.
Sharifi M; Bay C; Schwartz F; Skrocki L
Clin Cardiol; 2014 Feb; 37(2):78-82. PubMed ID: 24122947
[TBL] [Abstract][Full Text] [Related]
20. Managing pulmonary embolism from presentation to extended treatment.
Cohen AT; Dobromirski M; Gurwith MM
Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
